Products

Octride Depot 20mg Injection – Octreotide Acetate | Acromegaly & Neuroendocrine Tumor Treatment | Supplier & Exporter Octride Depot 20mg Injection contains Octreotide Acetate, a long-acting somatostatin analogue used for the treatment of acromegaly, neuroendocrine tumors, and severe diarrhea or flushing associated with carcinoid syndrome. It works by reducing the production of certain hormones in the body, particularly growth hormone and other substances that can cause symptoms related to hormone-secreting tumors. This medication is commonly prescribed when surgery, radiation, or other treatments are not effective or suitable. Octride Depot 20mg helps control hormone levels, relieve symptoms, and improve the overall quality of life in patients suffering from endocrine disorders. Ernest Oncology – Pharmaceutical Exporter from India supplies genuine Octride Depot 20mg Injection to hospitals, pharmacies, distributors, and healthcare institutions worldwide with competitive wholesale pricing and reliable international shipping. Product Information Product Name: Octride Depot 20mg Injection Generic Name: Octreotide Acetate Strength: 20 mg Form: Depot Injection (Long-acting) Drug Class: Somatostatin Analogue Manufacturer: Sun Pharmaceutical Industries Ltd. Packaging: 1 Vial with Diluent Route of Administration: Intramuscular Injection Mechanism of Action Octride Depot contains Octreotide, which mimics the natural hormone somatostatin. It inhibits the secretion of several hormones including growth hormone, insulin, glucagon, and serotonin. By controlling these hormones, the medicine helps manage symptoms associated with hormone-producing tumors and endocrine disorders. Uses of Octride Depot 20mg Injection Octride Depot Injection is prescribed for the treatment of: Acromegaly Neuroendocrine tumors Carcinoid syndrome VIPomas (vasoactive intestinal peptide tumors) Severe hormone-related diarrhea and flushing Benefits Controls excessive hormone secretion Reduces symptoms of carcinoid syndrome Helps manage growth hormone levels in acromegaly Long-acting depot formulation for convenient dosing Improves symptom control and patient comfort Dosage & Administration Octride Depot 20mg Injection is typically administered once every 4 weeks by intramuscular injection. The dosage and treatment schedule should always be determined by a qualified healthcare professional depending on the patient’s condition and response to therapy. Possible Side Effects Some patients may experience: Abdominal pain Nausea or vomiting Diarrhea or constipation Injection site discomfort Headache Serious side effects are rare but medical supervision is necessary during treatment. Storage Instructions Store at 2°C to 8°C (Refrigerated) Protect from direct light Do not freeze Ernest Oncology / Ernest Pharmaceutical Pvt. Ltd. is a trusted global exporter and supplier of specialty medicines including oncology, endocrinology, and rare disease treatments. We supply authentic pharmaceutical products with complete export documentation and worldwide delivery. We export medicines to: USA | UK | UAE | Saudi Arabia | Singapore | Australia | Thailand | Africa | Latin America | Europe Why Choose Ernest Oncology? Genuine pharmaceutical products Competitive bulk pricing Global distributor network Fast international delivery (DHL / Aramex / FedEx) Export documents including COA, MSDS, Invoice, Packing List 📞 Contact Ernest Oncology – Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Website www.oncologymedicinesupplier.com www.ernestempex.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 https://wa.me/919359902383

Hertraz 440mg (Trastuzumab) Injection – Global Supplier & Exporter | Ernest Oncology Hertraz 440mg Trastuzumab Injection – Targeted Therapy for HER2-Positive Breast & Gastric Cancer Hertraz 440mg Injection (Trastuzumab) is an advanced targeted monoclonal antibody therapy used for the treatment of HER2-positive breast cancer and HER2-positive metastatic gastric cancer. Trastuzumab works by targeting the HER2 receptor protein responsible for rapid cancer cell growth. Ernest Oncology, a trusted pharmaceutical exporter from India, supplies Hertraz 440mg (Trastuzumab) Injection to oncology hospitals, cancer treatment centers, pharmaceutical distributors, and global healthcare procurement companies across major international markets including Washington DC, London UK, Riyadh Saudi Arabia, Bangkok Thailand, Canberra Australia, Singapore, and Kingston Jamaica.What is Hertraz 440mg (Trastuzumab) Injection? Hertraz 440mg contains Trastuzumab, a monoclonal antibody that specifically targets HER2 (Human Epidermal Growth Factor Receptor-2) proteins on cancer cells. HER2-positive cancers produce excessive HER2 proteins, leading to aggressive tumor growth. Trastuzumab binds to these receptors and blocks the signals responsible for cancer cell proliferation. This therapy has significantly improved survival outcomes in patients with HER2-positive breast cancer and gastric cancer. Mechanism of Action Trastuzumab works by targeting HER2 receptors on cancer cells. Its key actions include: • Binding to HER2 receptors on tumor cells • Blocking signals that stimulate cancer growth • Activating immune system response against tumor cells • Preventing cancer cell division and survival Through these mechanisms, Trastuzumab helps control tumor growth and progression in HER2-positive cancers. Medical Uses of Hertraz 440mg Injection Doctors prescribe Hertraz (Trastuzumab) for several cancer treatment protocols: HER2-Positive Breast Cancer Used in early-stage and metastatic HER2-positive breast cancer treatment. Adjuvant Breast Cancer Therapy Often administered after surgery and chemotherapy to reduce cancer recurrence. Metastatic Breast Cancer Helps slow progression of advanced breast cancer. HER2-Positive Gastric Cancer Used in combination with chemotherapy for HER2-positive stomach cancer. Benefits of Hertraz 440mg (Trastuzumab) Injection • Highly effective targeted therapy for HER2-positive cancers • Improves survival rates in breast cancer patients • Works specifically against HER2 cancer cells • Can be combined with chemotherapy regimens • Recommended in global oncology treatment guidelines Product Information Product Name: Hertraz Injection Generic Name: Trastuzumab Strength: 440 mg Dosage Form: Injection / Lyophilized Powder Therapeutic Class: Anti-Cancer / Monoclonal Antibody Indication: HER2-positive breast cancer & gastric cancer Prescription: Required Global Demand for Trastuzumab Injection With the increasing incidence of HER2-positive breast cancer worldwide, demand for Trastuzumab targeted therapy injections continues to grow. Healthcare providers and pharmaceutical distributors in USA, UK, Saudi Arabia, Thailand, Australia, Singapore, and Jamaica frequently import Trastuzumab injections from trusted pharmaceutical exporters in India, such as Ernest Oncology. Hertraz 440mg Injection Exporter & Supplier Ernest Oncology is a globally recognized pharmaceutical exporter and distributor of oncology medicines from India. The company supplies medicines to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical wholesalers • Medical distributors • Government healthcare tenders • International NGOs and procurement agencies Why Choose Ernest Oncology? • Trusted Pharmaceutical Exporter from India • Global distribution network covering 100+ countries • GMP-compliant oncology medicines • Competitive bulk pricing for distributors • Secure international packaging • Fast export logistics and worldwide delivery • Complete pharmaceutical export documentation Export Documentation Provided Ernest Oncology provides complete pharmaceutical export documentation including: • Certificate of Analysis (COA) • Manufacturing License • Product Batch Release Certificate • MSDS (Material Safety Data Sheet) • Commercial Invoice & Packing List • Airway Bill (DHL / Aramex / FedEx) • Certificate of Origin These documents ensure smooth international customs clearance for pharmaceutical shipments. 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymediciensupplier.com www.ernestempex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 WhatsApp Direct Link https://wa.me/919359902383

Xtant 140mg (Estramustine) Tablet – Global Supplier & Exporter | Ernest Oncology Xtant 140mg Estramustine Tablets – Advanced Therapy for Prostate Cancer Treatment Xtant 140mg Tablet (Estramustine) is a specialized anti-cancer medicine used in the treatment of advanced prostate cancer. Estramustine combines properties of hormone therapy and chemotherapy, helping slow the growth of prostate cancer cells. Ernest Oncology, a trusted pharmaceutical exporter from India, supplies Xtant 140mg (Estramustine) Tablets to oncology hospitals, cancer treatment centers, pharmaceutical distributors, and global healthcare procurement companies across major international markets including Washington DC, London UK, Riyadh Saudi Arabia, Bangkok Thailand, Canberra Australia, Singapore, and Kingston Jamaica. What is Xtant 140mg (Estramustine) Tablet? Xtant 140mg contains Estramustine, a cytotoxic medication used primarily for the treatment of metastatic prostate cancer. Estramustine works by interfering with microtubule formation in cancer cells, preventing them from dividing and multiplying. It also affects hormone pathways involved in prostate cancer growth. Due to its dual mechanism, Estramustine is considered an important medicine in advanced prostate cancer treatment protocols worldwide. Mechanism of Action Estramustine works through several anti-cancer mechanisms: • Disrupts microtubule formation in cancer cells • Prevents cancer cell division and replication • Interferes with androgen-dependent tumor growth • Induces apoptosis (programmed cancer cell death) These actions help slow the progression of advanced prostate cancer. Medical Uses of Xtant 140mg Tablet Doctors prescribe Xtant (Estramustine) for: Advanced Prostate Cancer Used to treat metastatic prostate cancer, especially when the disease spreads beyond the prostate. Hormone-Resistant Prostate Cancer Helpful in patients whose cancer has progressed after hormone therapy. Combination Cancer Therapy Sometimes used alongside other anti-cancer medicines in prostate cancer treatment protocols. Benefits of Xtant 140mg (Estramustine) Tablet • Effective therapy for advanced prostate cancer • Combines hormonal and cytotoxic treatment effects • Helps slow tumor growth and cancer progression • Oral tablet therapy for convenient treatment • Used in international prostate cancer treatment guidelines Product Information Product Name: Xtant Tablet Generic Name: Estramustine Strength: 140 mg Dosage Form: Tablet Therapeutic Class: Anti-Cancer / Hormone-Chemotherapy Agent Indication: Advanced Prostate Cancer Prescription: Required Global Demand for Estramustine Tablets With the rising global incidence of prostate cancer, the demand for Estramustine-based therapies continues to grow. Healthcare providers and pharmaceutical distributors in USA, UK, Saudi Arabia, Thailand, Australia, Singapore, and Jamaica frequently import Estramustine tablets from trusted pharmaceutical exporters in India, such as Ernest Oncology. Xtant 140mg Tablet Exporter & Supplier Ernest Oncology is a globally recognized pharmaceutical exporter and distributor of oncology medicines from India. The company supplies medicines to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical wholesalers • Medical distributors • Government healthcare tenders Why Choose Ernest Oncology? • Trusted Pharmaceutical Exporter from India • Global distribution network covering 100+ countries •GMP-compliant medicines • Competitive bulk pricing for distributors • Secure international packaging • Fast export logistics and worldwide delivery • Complete pharmaceutical export documentation Export Documentation Provided Ernest Oncology provides complete pharmaceutical export documentation, including: • Certificate of Analysis (COA) • Manufacturing License • Product Batch Release Certificate • MSDS (Material Safety Data Sheet) • Commercial Invoice & Packing List • Airway Bill (DHL / Aramex / FedEx) • Certificate of Origin These documents ensure smooth international customs clearance for pharmaceutical shipments. 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymediciensupplier.com www.ernestempex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 WhatsApp Direct Link https://wa.me/919359902383

Xtane 25mg (Exemestane) Tablet—Global Supplier & Exporter | Ernest Oncology Xtane 25mg Exemestane Tablets—Hormone Therapy for Breast Cancer Treatment Xtane 25mg Tablet (Exemestane) is an effective hormonal anti-cancer medicine used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. Exemestane belongs to a class of medicines known as aromatase inhibitors, which reduce the production of estrogen in the body and help slow the growth of estrogen-dependent breast cancer cells. Ernest Oncology, a trusted pharmaceutical exporter from India, supplies Xtane 25mg (Exemestane) Tablets to oncology hospitals, cancer treatment centers, pharmaceutical distributors, and international healthcare procurement companies across major healthcare markets, including Washington DC, London UK, Riyadh Saudi Arabia, Bangkok Thailand, Canberra Australia, Singapore, and Kingston Jamaica. What is Xtane 25 mg (Exemestane) Tablet? Xtane 25 mg contains Exemestane, a steroidal aromatase inhibitor that reduces estrogen levels in the body. Many breast cancers rely on estrogen to grow, and by lowering estrogen production, Exemestane helps slow or stop the growth of cancer cells. Exemestane therapy is widely used as part of adjuvant hormonal therapy in breast cancer treatment protocols worldwide. Mechanism of Action Exemestane works by inhibiting the aromatase enzyme, which is responsible for converting androgens into estrogen. Its therapeutic actions include: • Blocking estrogen production in postmenopausal women • Reducing hormone-dependent tumor growth • Preventing recurrence of breast cancer • Slowing the progression of metastatic disease This mechanism makes Exemestane an essential therapy for hormone-sensitive breast cancer treatment. Medical Uses of Xtane 25mg Tablet Doctors prescribe Xtane (Exemestane) for several breast cancer treatment protocols: Hormone-Receptor Positive Breast Cancer Used for postmenopausal women with estrogen receptor-positive breast cancer. Adjuvant Breast Cancer Therapy Often used after 2–3 years of tamoxifen therapy to reduce cancer recurrence. Advanced or Metastatic Breast Cancer Used in patients whose disease has progressed after other hormone therapies. Long-Term Cancer Prevention Helps reduce the risk of recurrence in hormone-sensitive breast cancers. Benefits of Xtane 25mg (Exemestane) Tablet • Effective hormonal therapy for breast cancer • Reduces estrogen levels that stimulate tumor growth • Helps prevent recurrence of hormone-dependent cancers • Oral tablet treatment for convenient therapy • Recommended in international oncology treatment guidelines Product Information Product Name: Xtane Tablet Generic Name: Exemestane Strength: 25 mg Dosage Form: Tablet Therapeutic Class: Anti-Cancer / Aromatase Inhibitor Indication: Hormone receptor-positive breast cancer Prescription: Required Global Demand for Exemestane Tablets With the increasing global incidence of breast cancer, demand for aromatase inhibitor therapies such as Exemestane continues to rise. Healthcare providers and pharmaceutical distributors in USA, UK, Saudi Arabia, Thailand, Australia, Singapore, and Jamaica frequently import exemestane tablets from trusted pharmaceutical exporters in India, such as Ernest Oncology. Xtane 25mg Tablet Exporter & Supplier Ernest Oncology is a globally recognized pharmaceutical exporter and distributor of oncology medicines from India. The company supplies medicines to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical wholesalers • Medical distributors • Government healthcare tenders • International NGOs and procurement agencies Why Choose Ernest Oncology? • Trusted Pharmaceutical Exporter from India • Global distribution network covering 100+ countries • GMP-compliant medicines • Competitive bulk pricing for distributors • Secure international packaging • Fast export logistics and worldwide delivery • Complete pharmaceutical export documentation Export Documentation Provided Ernest Oncology provides complete pharmaceutical export documentation, including: • Certificate of Analysis (COA) • Manufacturing License • Product Batch Release Certificate • MSDS (Material Safety Data Sheet) • Commercial Invoice & Packing List • Airway Bill (DHL / Aramex / FedEx) • Certificate of Origin These documents ensure smooth international customs clearance for pharmaceutical shipments. 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymediciensupplier.com www.ernestempex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 WhatsApp Direct Link https://wa.me/919359902383

Veenat 100mg (Imatinib Mesylate) Capsule Strip / Tablet – Global Supplier & Exporter | Ernest Oncology Veenat 100mg Imatinib Mesylate Capsules – Targeted Therapy for Leukemia & Gastrointestinal Tumors Veenat 100mg Capsule/Tablet (Imatinib Mesylate) is a widely used targeted anti-cancer medicine prescribed for the treatment of chronic myeloid leukemia (CML), acute lymphoblastic leukemia (ALL), and gastrointestinal stromal tumors (GIST). Imatinib belongs to the class of medicines called tyrosine kinase inhibitors (TKIs) that block abnormal enzymes responsible for cancer cell growth. Ernest Oncology, a trusted pharmaceutical exporter from India, supplies Veenat 100mg (Imatinib Mesylate) Capsule Strip/Tablets to oncology hospitals, cancer treatment centers, pharmaceutical distributors, and global healthcare procurement companies across major healthcare markets, including Washington DC, London UK, Riyadh Saudi Arabia, Bangkok Thailand, Canberra Australia, Singapore, and Kingston Jamaica. What is Veenat 100 mg (Imatinib Mesylate)? Veenat 100 mg contains Imatinib Mesylate, a revolutionary targeted therapy designed to block BCR-ABL tyrosine kinase, an abnormal protein responsible for uncontrolled growth of leukemia cells. Imatinib was one of the first targeted cancer therapies and significantly improved survival rates for patients with chronic myeloid leukemia. By blocking cancer-causing enzymes, Imatinib helps slow or stop the multiplication of malignant cells. Mechanism of Action Imatinib works by inhibiting abnormal tyrosine kinase enzymes that stimulate cancer cell growth. Its anti-cancer actions include: • Blocking BCR-ABL tyrosine kinase signaling • Preventing uncontrolled proliferation of leukemia cells • Interrupting tumor growth signals • Promoting apoptosis (programmed cancer cell death) These actions make Imatinib one of the most effective targeted therapies for leukemia and certain solid tumors. Medical Uses of Veenat 100mg Capsule/Tablet Doctors prescribe Veenat (Imatinib Mesylate) for several cancer treatment protocols: Chronic Myeloid Leukemia (CML) Primary treatment for Philadelphia chromosome-positive CML patients. Acute Lymphoblastic Leukemia (ALL) Used for Philadelphia chromosome-positive ALL in combination with chemotherapy. Gastrointestinal Stromal Tumors (GIST) Effective treatment for unresectable or metastatic GIST tumors. Other Rare Tumors Sometimes prescribed for cancers involving abnormal tyrosine kinase signaling pathways. Benefits of Veenat 100mg (Imatinib Mesylate) • Advanced targeted therapy for leukemia treatment • Blocks cancer-causing tyrosine kinase enzymes • Helps control progression of blood cancers • Oral capsule/tablet therapy for convenient treatment • Recommended in global oncology treatment guidelines Product Information Product Name: Veenat Capsule / Tablet Generic Name: Imatinib Mesylate Strength: 100 mg Packaging: Capsule Strip / Tablet Strip Dosage Form: Capsule / Tablet Therapeutic Class: Anti-Cancer / Tyrosine Kinase Inhibitor Indication: CML, ALL, GIST Prescription: Required Global Demand for Imatinib Mesylate With the rising global incidence of leukemia and gastrointestinal stromal tumors, the demand for Imatinib targeted therapy medicines continues to increase. Healthcare providers and pharmaceutical distributors in USA, UK, Saudi Arabia, Thailand, Australia, Singapore, and Jamaica frequently import Imatinib capsules and tablets from trusted pharmaceutical exporters in India, such as Ernest Oncology. Veenat 100mg Exporter & Supplier Ernest Oncology is a globally recognized pharmaceutical exporter and distributor of oncology medicines from India. The company supplies medicines to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical wholesalers • Medical distributors • Government healthcare tenders • International NGOs and procurement agencies Why Choose Ernest Oncology? • Trusted Pharmaceutical Exporter from India • Global distribution network covering 100+ countries • GMP compliant medicines • Competitive bulk pricing for distributors • Secure international packaging • Fast export logistics and worldwide delivery • Complete pharmaceutical export documentation Export Documentation Provided Ernest Oncology provides complete pharmaceutical export documentation including: • Certificate of Analysis (COA) • Manufacturing License • Product Batch Release Certificate • MSDS (Material Safety Data Sheet) • Commercial Invoice & Packing List • Airway Bill (DHL / Aramex / FedEx) • Certificate of Origin These documents ensure smooth international customs clearance for pharmaceutical shipments. 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymediciensupplier.com www.ernestempex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 WhatsApp Direct Link https://wa.me/919359902383

Hernix Neratinib 40mg Tablet – Global Supplier & Exporter | Ernest Oncology Hernix Neratinib 40mg Tablet Hernix Neratinib 40mg Tablet contains Neratinib, a targeted anti-cancer medicine used in the treatment of HER2-positive breast cancer. It belongs to the class of tyrosine kinase inhibitors (TKIs) and works by blocking the activity of proteins that promote cancer cell growth. Ernest Oncology, a division of Ernest Pharmaceutical Pvt. Ltd., is a trusted global exporter and bulk supplier of oncology medicines, supplying Hernix Neratinib 40mg tablets to hospitals, oncology clinics, pharmaceutical distributors, and international wholesalers worldwide. What is Hernix Neratinib 40mg Tablet? Hernix Neratinib Tablet is a targeted therapy designed to treat HER2-positive breast cancer. The active ingredient Neratinib blocks multiple HER family receptors, which are responsible for tumor cell growth and proliferation. This treatment is often prescribed after trastuzumab-based therapy to reduce the risk of cancer recurrence. Mechanism of Action Neratinib works by irreversibly inhibiting HER1, HER2, and HER4 tyrosine kinases. Its mechanism includes: • Blocking HER receptor signaling pathways • Preventing cancer cell growth and division • Reducing tumor progression • Helping prevent recurrence of HER2-positive breast cancer This targeted action helps control cancer progression more effectively. Indications Hernix Neratinib 40mg Tablet is used for the treatment of: • HER2-Positive Early Breast Cancer • Extended adjuvant treatment after trastuzumab therapy • Advanced HER2-positive breast cancer Dosage & Administration Typical dosage guidelines: • 240 mg once daily (6 tablets of 40 mg) • Taken with food • Tablets should be swallowed whole with water Treatment must be taken under the supervision of an oncologist. Key Benefits of Hernix Neratinib 40mg Tablet ✔ Advanced targeted therapy for HER2 breast cancer ✔ Helps reduce risk of cancer recurrence ✔ Blocks HER receptor signaling pathways ✔ Effective oral anti-cancer treatment ✔ Improves long-term cancer management outcomes Possible Side Effects Some patients may experience: • Diarrhea • Nausea • Fatigue • Vomiting • Abdominal pain • Loss of appetite Patients should be monitored regularly during treatment. Product Specifications Product Name: Hernix Generic Name: Neratinib Strength: 40 mg Dosage Form: Tablet Therapeutic Class: Anti-Cancer / Tyrosine Kinase Inhibitor Packaging: Bottle / Blister Storage: Store below 25°C Ernest Oncology supplies Hernix Neratinib 40mg tablets worldwide, including: USA • United Kingdom • UAE • Saudi Arabia • Australia • Singapore • South Africa • Thailand • Jamaica • Europe • Africa • Middle East • Latin America We supply to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical distributors • Government healthcare tenders • International wholesalers Why Buy From Ernest Oncology? ✔ Trusted Oncology Medicine Exporter from India ✔ Competitive bulk and wholesale pricing ✔ 100% genuine pharmaceutical products ✔ GMP compliant supply ✔ Worldwide delivery via DHL / FedEx / Aramex ✔ Reliable B2B pharmaceutical partner Export Documentation Provided • Certificate of Analysis (COA) • MSDS (Material Safety Data Sheet) • Batch Release Certificate • Commercial Invoice • Packing List • Airway Bill • GMP Certificates 📞 Contact Ernest Oncology – Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymedicinesupplier.com www.ernestempex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 https://wa.me/919359902383

Mabtas 500mg Injection (Rituximab) – Global Supplier & Exporter | Ernest Oncology Mabtas 500mg Injection Mabtas 500mg Injection contains Rituximab, a monoclonal antibody medicine widely used for the treatment of blood cancers and certain autoimmune diseases. It works by targeting the CD20 protein found on B-lymphocytes, helping the immune system destroy abnormal cells. Ernest Oncology, a division of Ernest Pharmaceutical Pvt. Ltd., is a trusted global exporter and bulk supplier of oncology medicines and biologic therapies, supplying Mabtas 500mg injections to hospitals, oncology clinics, pharmaceutical distributors, and international wholesalers worldwide. What is Mabtas 500mg Injection? Mabtas Injection is a targeted biologic therapy designed to treat cancers that affect B-cells, a type of white blood cell. The active ingredient Rituximab binds to the CD20 antigen present on B-cells and triggers immune-mediated destruction of cancerous cells. It is also used to treat certain autoimmune diseases by reducing abnormal immune responses. Mechanism of Action Rituximab works by targeting the CD20 antigen on B-cells. Its mechanism includes: • Binding to CD20 proteins on B-lymphocytes • Activating immune-mediated destruction of abnormal cells • Inducing apoptosis (programmed cell death) in cancer cells • Reducing abnormal immune system activity This targeted therapy helps eliminate cancerous B-cells and control disease progression. Indications Mabtas 500mg Injection is used for the treatment of: • Non-Hodgkin’s Lymphoma (NHL) • Chronic Lymphocytic Leukemia (CLL) • Rheumatoid Arthritis • Granulomatosis with Polyangiitis (GPA) • Microscopic Polyangiitis (MPA) It may be used alone or in combination with chemotherapy medicines. Dosage & Administration Typical dosage guidelines: • Administered as intravenous infusion • Dosage based on body surface area and treatment protocol • Treatment schedule determined by the oncologist or physician Infusion should be given in a hospital or clinical setting under medical supervision. Key Benefits of Mabtas 500mg Injection ✔ Targeted monoclonal antibody therapy ✔ Effective treatment for blood cancers ✔ Helps eliminate abnormal B-cells ✔ Used in both oncology and autoimmune disease therapy ✔ Proven treatment option in modern immunotherapy Possible Side Effects Some patients may experience: • Infusion reactions • Fever or chills • Fatigue • Nausea • Low white blood cell count • Increased risk of infections Patients should be monitored during infusion therapy. Product Specifications Product Name: Mabtas Generic Name: Rituximab Strength: 500 mg Dosage Form: Injection Therapeutic Class: Anti-Cancer / Monoclonal Antibody Packaging: Vial Storage: Store in refrigerator (2°C – 8°C) Ernest Oncology supplies Mabtas 500mg injections worldwide, including: USA • United Kingdom • UAE • Saudi Arabia • Australia • Singapore • South Africa • Thailand • Jamaica • Europe • Africa • Middle East • Latin America We supply to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical distributors • Government healthcare tenders • International wholesalers Why Buy From Ernest Oncology? ✔ Trusted Oncology Medicine Exporter from India ✔ Competitive bulk and wholesale pricing ✔ 100% genuine pharmaceutical products ✔ GMP compliant supply ✔ Worldwide delivery via DHL / FedEx / Aramex ✔ Reliable B2B pharmaceutical partner Export Documentation Provided • Certificate of Analysis (COA) • MSDS (Material Safety Data Sheet) • Batch Release Certificate • Commercial Invoice • Packing List • Airway Bill • GMP Certificates 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymedicinesupplier.com www.ernestempex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 https://wa.me/919359902383

Gazyva 1000mg Injection (Obinutuzumab) – Global Supplier & Exporter | Ernest Oncology Gazyva 1000mg Injection Gazyva 1000mg Injection contains Obinutuzumab, a monoclonal antibody medicine used in the treatment of certain types of blood cancers, including chronic lymphocytic leukemia (CLL) and follicular lymphoma. It works by targeting specific proteins on cancer cells and helping the immune system destroy them. Ernest Oncology, a division of Ernest Pharmaceutical Pvt. Ltd., is a trusted global exporter and bulk supplier of oncology medicines, supplying Gazyva 1000mg injections to hospitals, oncology centers, pharmaceutical distributors, and international wholesalers worldwide. What is Gazyva 1000mg Injection? Gazyva Injection is a targeted monoclonal antibody therapy designed to treat certain B-cell cancers. The active ingredient Obinutuzumab binds to the CD20 protein present on B-lymphocytes, triggering immune-mediated destruction of cancerous cells. This therapy helps improve treatment outcomes when used alone or in combination with other chemotherapy medicines. Mechanism of Action Obinutuzumab works by targeting the CD20 antigen on B-cells. Its mechanism includes: • Binding to CD20 proteins on cancerous B-cells • Activating immune system attack on tumor cells • Inducing direct cell death (apoptosis) • Enhancing antibody-dependent cellular cytotoxicity This targeted approach helps eliminate cancer cells while sparing healthy tissues. Indications Gazyva 1000mg Injection is used for the treatment of: • Chronic Lymphocytic Leukemia (CLL) • Follicular Lymphoma (FL) • Relapsed or Refractory Non-Hodgkin Lymphoma It is often used in combination with chemotherapy drugs such as chlorambucil or bendamustine. Dosage & Administration Typical dosage guidelines: • Administered as intravenous infusion • Initial dose followed by scheduled maintenance doses • Dosage depends on treatment protocol and patient condition Treatment should be administered under the supervision of an oncologist in a clinical setting. Key Benefits of Gazyva 1000mg Injection ✔ Targeted monoclonal antibody therapy for blood cancers ✔ Effective treatment for CLL and follicular lymphoma ✔ Enhances immune system destruction of cancer cells ✔ Often used in combination cancer therapy ✔ Improves treatment outcomes in B-cell malignancies Possible Side Effects Some patients may experience: • Infusion-related reactions • Fever or chills • Low white blood cell count • Fatigue • Nausea • Increased risk of infections Patients should be monitored carefully during treatment. Product Specifications Product Name: Gazyva Generic Name: Obinutuzumab Strength: 1000 mg Dosage Form: Injection Therapeutic Class: Anti-Cancer / Monoclonal Antibody Packaging: Vial Storage: Store in refrigerator (2°C – 8°C) Ernest Oncology supplies Gazyva 1000mg injections worldwide, including: USA • United Kingdom • UAE • Saudi Arabia • Australia • Singapore • South Africa • Thailand • Jamaica • Europe • Africa • Middle East • Latin America We supply to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical distributors • Government healthcare tenders • International wholesalers Why Buy From Ernest Oncology? ✔ Trusted Oncology Medicine Exporter from India ✔ Competitive bulk and wholesale pricing ✔ 100% genuine pharmaceutical products ✔ GMP compliant supply ✔ Worldwide delivery via DHL / FedEx / Aramex ✔ Reliable B2B pharmaceutical partner Export Documentation Provided • Certificate of Analysis (COA) • MSDS (Material Safety Data Sheet) • Batch Release Certificate • Commercial Invoice • Packing List • Airway Bill • GMP Certificates 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymedicinesupplier.com www.ernestempex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 https://wa.me/919359902383

Sorafenat 200mg (Sorafenib) Tablet – Global Supplier & Exporter | Ernest Oncology Sorafenat 200mg Sorafenib Tablets—Targeted Therapy for Liver, Kidney & Thyroid Cancer Sorafenat 200mg Tablet (Sorafenib) is an advanced targeted anti-cancer medication used for the treatment of liver cancer (hepatocellular carcinoma), kidney cancer (renal cell carcinoma), and thyroid cancer. Sorafenib belongs to a group of medicines known as multi-kinase inhibitors, which block signals responsible for cancer cell growth and tumor blood vessel formation. Ernest Oncology, a trusted pharmaceutical exporter from India, supplies Sorafenat 200mg (Sorafenib) Tablets to oncology hospitals, cancer treatment centers, pharmaceutical distributors, and international healthcare procurement companies across major healthcare markets including Washington DC, London UK, Riyadh Saudi Arabia, Bangkok Thailand, Canberra Australia, Singapore, and Kingston Jamaica. What is Sorafenat 200mg (Sorafenib) Tablet? Sorafenat 200mg contains Sorafenib, a targeted therapy that works by blocking multiple proteins involved in tumor growth and blood vessel formation. Sorafenib inhibits several important kinase enzymes that allow cancer cells to multiply and spread. By blocking these pathways, Sorafenib helps slow the progression of cancer and reduce tumor growth. Mechanism of Action Sorafenib works through dual anti-cancer mechanisms: • Inhibits tumor cell proliferation • Blocks angiogenesis (formation of blood vessels feeding tumors) It targets several kinase pathways, including • RAF kinase • VEGFR (vascular endothelial growth factor receptor) • PDGFR (platelet-derived growth factor receptor) Through these mechanisms, Sorafenib prevents cancer cells from receiving nutrients and signals needed for growth. Medical Uses of Sorafenat 200mg Tablet Doctors prescribe Sorafenat (Sorafenib) for several types of cancer: Liver Cancer (Hepatocellular Carcinoma—HCC) One of the most widely used treatments for advanced liver cancer. Kidney Cancer (Renal Cell Carcinoma – RCC) Used to treat advanced kidney cancer when other treatments are not effective. Thyroid Cancer Used in patients with radioactive iodine-resistant differentiated thyroid cancer. Benefits of Sorafenat 200mg (Sorafenib) Tablet • Advanced targeted therapy for multiple cancers • Blocks tumor growth and blood vessel formation • Helps slow progression of metastatic cancer • Oral tablet therapy for convenient treatment • Recommended in international oncology treatment guidelines Product Information Product Name: Sorafenat Tablet Generic Name: Sorafenib Strength: 200 mg Dosage Form: Tablet Therapeutic Class: Anti-Cancer / Multi-Kinase Inhibitor Indication: Liver Cancer, Kidney Cancer, Thyroid Cancer Prescription: Required Global Demand for Sorafenib Tablets The increasing global incidence of liver cancer and kidney cancer has significantly increased demand for Sorafenib targeted therapy medicines. Healthcare providers and pharmaceutical distributors in USA, UK, Saudi Arabia, Thailand, Australia, Singapore, and Jamaica frequently import Sorafenib tablets from trusted pharmaceutical exporters in India, such as Ernest Oncology. Sorafenat 200mg Tablet Exporter & Supplier Ernest Oncology is a globally recognized pharmaceutical exporter and distributor of oncology medicines from India. The company supplies medicines to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical wholesalers • Medical distributors • Government healthcare tenders • International NGOs and procurement agencies Why Choose Ernest Oncology? • Trusted Pharmaceutical Exporter from India • Global distribution network covering 100+ countries • GMP-compliant medicines • Competitive bulk pricing for distributors • Secure international packaging • Fast export logistics and worldwide delivery • Complete pharmaceutical export documentation Export Documentation Provided Ernest Oncology provides complete pharmaceutical export documentation including: • Certificate of Analysis (COA) • Manufacturing License • Product Batch Release Certificate • MSDS (Material Safety Data Sheet) • Commercial Invoice & Packing List • Airway Bill (DHL / Aramex / FedEx) • Certificate of Origin These documents ensure smooth international customs clearance for pharmaceutical shipments. 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymediciensupplier.com www.ernestempex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 WhatsApp Direct Link https://wa.me/919359902383

Pomalid 4mg (Pomalidomide) Capsule – Global Supplier & Exporter | Ernest Oncology Pomalid 4mg Pomalidomide Capsules – Advanced Therapy for Multiple Myeloma Pomalid 4mg Capsule (Pomalidomide) is an advanced immunomodulatory anti-cancer medicine used for the treatment of relapsed or refractory multiple myeloma, a serious blood cancer affecting plasma cells in bone marrow. Pomalidomide belongs to the class of medicines known as IMiDs (Immunomodulatory Drugs) that enhance the body’s immune response against cancer cells while inhibiting tumor growth. Ernest Oncology, a trusted pharmaceutical exporter from India, supplies Pomalid 4mg (Pomalidomide) Capsules to oncology hospitals, cancer treatment centers, pharmaceutical distributors, and international healthcare procurement companies across major healthcare markets including Washington DC, London UK, Riyadh Saudi Arabia, Bangkok Thailand, Canberra Australia, Singapore, and Kingston Jamaica. What is Pomalid 4mg (Pomalidomide) Capsule? Pomalid 4 mg contains Pomalidomide, a next-generation immunomodulatory therapy derived from thalidomide. It is widely prescribed for patients whose multiple myeloma has returned after previous treatments such as lenalidomide or bortezomib. Pomalidomide works by strengthening immune responses and stopping the abnormal proliferation of malignant plasma cells responsible for blood cancer progression. Mechanism of Action Pomalidomide works through multiple therapeutic mechanisms: • Enhances immune system response against cancer cells • Inhibits angiogenesis (formation of tumor-feeding blood vessels) • Suppresses abnormal plasma cell growth in bone marrow • Induces apoptosis (programmed cancer cell death) These combined actions make Pomalidomide one of the most effective immunomodulatory therapies for multiple myeloma. Medical Uses of Pomalid 4mg Capsule Doctors prescribe Pomalid (Pomalidomide) for several hematologic cancer treatments: Multiple Myeloma Used with low-dose dexamethasone for treatment of relapsed or refractory multiple myeloma. Advanced Plasma Cell Disorders Helps manage disease progression when earlier therapies fail. Combination Cancer Therapy Often used alongside other anti-cancer medicines in advanced blood cancer treatment protocols. Benefits of Pomalid 4 mg (Pomalidomide) Capsule • Advanced immunomodulatory therapy for multiple myeloma • Enhances immune system's ability to attack cancer cells • Helps slow disease progression in relapsed patients • Oral capsule treatment for convenient administration • Recommended in international hematology and oncology guidelines Product Information Product Name: Pomalid Capsule Generic Name: Pomalidomide Strength: 4 mg Dosage Form: Capsule Therapeutic Class: Anti-Cancer / Immunomodulatory Agent Indication: Multiple Myeloma Prescription: Required Global Demand for Pomalidomide Capsules The global rise in multiple myeloma cases has increased demand for Pomalidomide therapy medicines. Healthcare providers and pharmaceutical distributors in USA, UK, Saudi Arabia, Thailand, Australia, Singapore, and Jamaica frequently import Pomalidomide capsules from trusted pharmaceutical exporters in India such as Ernest Oncology. Pomalid 4 mg Capsule Exporter & Supplier Ernest Oncology is a globally recognized pharmaceutical exporter and distributor of oncology medicines from India. The company supplies medicines to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical wholesalers • Medical distributors • Government healthcare tenders • International NGOs and procurement agencies Why Choose Ernest Oncology? • Trusted Pharmaceutical Exporter from India • Global distribution network covering 100+ countries • GMP-compliant medicines • Competitive bulk pricing for distributors • Secure international packaging • Fast export logistics and worldwide delivery • Complete pharmaceutical export documentation Export Documentation Provided Ernest Oncology provides complete pharmaceutical export documentation, including: • Certificate of Analysis (COA) • Manufacturing License • Product Batch Release Certificate • MSDS (Material Safety Data Sheet) • Commercial Invoice & Packing List • Airway Bill (DHL / Aramex / FedEx) • Certificate of Origin These documents ensure smooth international customs clearance for pharmaceutical shipments. 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymediciensupplier.com www.ernestempex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 WhatsApp Direct Link https://wa.me/919359902383

Pomalid 2mg (Pomalidomide) Capsule—Global Supplier & Exporter | Ernest Oncology Pomalid 2mg Pomalidomide Capsules – Advanced Therapy for Multiple Myeloma Treatment Pomalid 2 mg Capsule (Pomalidomide) is an advanced immunomodulatory anti-cancer medicine used in the treatment of relapsed or refractory multiple myeloma, a serious type of blood cancer that affects plasma cells in the bone marrow. Pomalidomide belongs to the class of medicines known as IMiDs (Immunomodulatory Drugs) that help the immune system fight cancer while suppressing tumor growth. Ernest Oncology, a trusted pharmaceutical exporter from India, supplies Pomalid 2mg (Pomalidomide) Capsules to oncology hospitals, cancer treatment centers, pharmaceutical distributors, and global healthcare procurement companies across major healthcare markets, including Washington DC, London UK, Riyadh Saudi Arabia, Bangkok Thailand, Canberra Australia, Singapore, and Kingston Jamaica. What is Pomalid 2 mg (Pomalidomide) Capsule? Pomalid 2mg contains Pomalidomide, a potent next-generation immunomodulatory agent derived from thalidomide. It helps strengthen the immune response against cancer cells while preventing abnormal plasma cell growth. Pomalidomide therapy is widely used in advanced multiple myeloma treatment protocols worldwide, particularly for patients who have previously been treated with medicines such as Lenalidomide and Bortezomib. Mechanism of Action Pomalidomide works through several important anti-cancer mechanisms: • Enhances immune system activity against malignant cells • Inhibits angiogenesis (formation of blood vessels feeding tumors) • Suppresses abnormal plasma cell proliferation in bone marrow • Promotes apoptosis (programmed cancer cell death) These mechanisms make Pomalidomide a powerful targeted immunotherapy for blood cancers. Medical Uses of Pomalid 2 mg Capsule Doctors prescribe Pomalid (Pomalidomide) for several hematologic cancer treatments: Multiple Myeloma Used with low-dose dexamethasone for patients with relapsed or refractory multiple myeloma. Advanced Plasma Cell Disorders Helps control disease progression in patients whose cancer has returned after previous therapies. Long-Term Disease Management Used as part of combination therapy strategies in advanced blood cancer treatment . Benefits of Pomalid 2mg (Pomalidomide) Capsule • Advanced immunomodulatory therapy for multiple myeloma • Boosts immune response against cancer cells • Helps slow tumor growth and disease progression • Convenient oral capsule therapy • Recommended in global hematology and oncology treatment guidelines Product Information Product Name: Pomalid Capsule Generic Name: Pomalidomide Strength: 2 mg Dosage Form: Capsule Therapeutic Class: Anti-Cancer / Immunomodulatory Agent Indication: Multiple Myeloma Prescription: Required Global Demand for Pomalidomide Capsules With increasing global cases of multiple myeloma and blood cancers, demand for Pomalidomide therapy medicines continues to grow worldwide. Healthcare providers and pharmaceutical distributors in USA, UK, Saudi Arabia, Thailand, Australia, Singapore, and Jamaica frequently import Pomalidomide capsules from trusted pharmaceutical exporters in India such as Ernest Oncology. Pomalid 2 mg Capsule Exporter & Supplier Ernest Oncology is a globally recognized pharmaceutical exporter and distributor of oncology medicines from India. The company supplies medicines to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical wholesalers • Medical distributors • Government healthcare tenders • International NGOs and procurement agencies Why Choose Ernest Oncology? • Trusted Pharmaceutical Exporter from India • Global distribution network covering 100+ countries • GMP-compliant medicines • Competitive bulk pricing for distributors • Secure international packaging • Fast export logistics and worldwide delivery • Complete pharmaceutical export documentation Export Documentation Provided Ernest Oncology provides complete pharmaceutical export documentation, including: • Certificate of Analysis (COA) • Manufacturing License • Product Batch Release Certificate • MSDS (Material Safety Data Sheet) • Commercial Invoice & Packing List • Airway Bill (DHL / Aramex / FedEx) • Certificate of Origin These documents ensure smooth international customs clearance for pharmaceutical shipments. 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymediciensupplire.com www.ernestempex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 WhatsApp Direct Link https://wa.me/919359902383

Pomalid 1 mg (Pomalidomide) Capsule—Global Supplier & Exporter | Ernest Oncology Pomalid 1mg Pomalidomide Capsules – Advanced Therapy for Multiple Myeloma Pomalid 1 mg Capsule (Pomalidomide) is a powerful immunomodulatory anti-cancer medicine used for the treatment of relapsed or refractory multiple myeloma. Pomalidomide belongs to a class of medicines known as IMiDs (Immunomodulatory Drugs), which enhance the immune system’s ability to fight cancer cells and inhibit tumor growth. Ernest Oncology, a trusted pharmaceutical exporter from India, supplies Pomalid 1 mg (Pomalidomide) Capsules to oncology hospitals, cancer treatment centers, pharmaceutical distributors, and international medical procurement companies across major healthcare markets including Washington DC, London UK, Riyadh Saudi Arabia, Bangkok Thailand, Canberra Australia, Singapore, and Kingston Jamaica. What is Pomalid 1 mg (Pomalidomide) Capsule? Pomalid 1 mg contains Pomalidomide, a next-generation immunomodulatory agent derived from thalidomide. It works by strengthening the body’s immune response against cancer cells and preventing abnormal plasma cells from multiplying. Pomalidomide therapy is widely used in advanced multiple myeloma treatment protocols worldwide, especially for patients who have previously received therapies such as lenalidomide and bortezomib. Mechanism of Action Pomalidomide works through several anti-cancer mechanisms: • Stimulates immune system cells to destroy cancer cells • Inhibits angiogenesis (formation of blood vessels feeding tumors) • Suppresses abnormal plasma cell growth in bone marrow • Promotes apoptosis (programmed death of malignant cells) These mechanisms make Pomalidomide one of the most effective targeted immunomodulatory treatments for multiple myeloma. Medical Uses of Pomalid 1 mg Capsule Doctors prescribe Pomalid (Pomalidomide) for several hematologic cancer treatments: Multiple Myeloma Used in combination with dexamethasone to treat relapsed or refractory multiple myeloma. Advanced Plasma Cell Disorders Helps control disease progression in patients whose cancer has returned after previous therapies. Maintenance Therapy Sometimes used as part of long-term management strategies in advanced blood cancers. Benefits of Pomalid 1 mg (Pomalidomide) Capsule • Advanced immunomodulatory therapy for multiple myeloma • Enhances immune response against cancer cells • Helps control tumor growth and progression • Oral capsule therapy for convenient treatment • Recommended in global hematology and oncology treatment guidelines Product Information Product Name: Pomalid Capsule Generic Name: Pomalidomide Strength: 1 mg Dosage Form: Capsule Therapeutic Class: Anti-Cancer / Immunomodulatory Agent Indication: Multiple Myeloma Prescription: Required Global Demand for Pomalidomide Capsules The increasing global incidence of multiple myeloma and hematologic cancers has significantly increased demand for Pomalidomide therapy medicines. Healthcare providers and pharmaceutical distributors in USA, UK, Saudi Arabia, Thailand, Australia, Singapore, and Jamaica frequently import Pomalidomide capsules from reliable pharmaceutical exporters in India, such as Ernest Oncology. Pomalid 1 mg Capsule Exporter & Supplier Ernest Oncology is a globally recognized pharmaceutical exporter and distributor of oncology medicines from India. The company supplies medicines to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical wholesalers • Medical distributors • Government healthcare tenders • International NGOs and procurement agencies Why Choose Ernest Oncology? • Trusted Pharmaceutical Exporter from India • Global distribution network covering 100+ countries • GMP-compliant medicines • Competitive bulk pricing for distributors • Secure international packaging • Fast export logistics and worldwide delivery • Complete pharmaceutical export documentation Export Documentation Provided Ernest Oncology provides complete pharmaceutical export documentation including: • Certificate of Analysis (COA) • Manufacturing License • Product Batch Release Certificate • MSDS (Material Safety Data Sheet) • Commercial Invoice & Packing List • Airway Bill (DHL / Aramex / FedEx) • Country of Origin Certificate These documents ensure smooth international customs clearance for pharmaceutical shipments. 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD] 🌐 Websites www.oncologymediciensupplier.com www.ernestempex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 WhatsApp Direct Link https://wa.me/919359902383